Spiro-piperidine inhibitors
    2.
    发明授权
    Spiro-piperidine inhibitors 有权
    螺哌啶抑制剂

    公开(公告)号:US08557836B2

    公开(公告)日:2013-10-15

    申请号:US12545501

    申请日:2009-08-21

    摘要: Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 protein.

    摘要翻译: 提供能够通过与M2跨膜蛋白相互作用来调节甲型流感病毒的活性的化合物。 还提供了用于治疗受甲型流感感染的疾病状态或感染的方法,其包括施用包含已被鉴定为能够与M2蛋白相互作用的一种或多种化合物的组合物。

    Adamantane analogs
    3.
    发明授权
    Adamantane analogs 有权
    金刚烷类似物

    公开(公告)号:US09301950B2

    公开(公告)日:2016-04-05

    申请号:US13391519

    申请日:2010-07-30

    摘要: Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 protein.

    摘要翻译: 提供能够通过与M2跨膜蛋白相互作用来调节甲型流感病毒的活性的化合物。 还提供了用于治疗受甲型流感感染的疾病状态或感染的方法,其包括施用包含已被鉴定为能够与M2蛋白相互作用的一种或多种化合物的组合物。

    SPIRO-PIPERIDINE INHIBITORS
    6.
    发明申请
    SPIRO-PIPERIDINE INHIBITORS 有权
    螺吡啶抑制剂

    公开(公告)号:US20100069420A1

    公开(公告)日:2010-03-18

    申请号:US12545501

    申请日:2009-08-21

    摘要: Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 protein.

    摘要翻译: 提供能够通过与M2跨膜蛋白相互作用来调节甲型流感病毒的活性的化合物。 还提供了用于治疗受甲型流感感染的疾病状态或感染的方法,其包括施用包含已被鉴定为能够与M2蛋白相互作用的一种或多种化合物的组合物。